Arrayit Partners with WSU to Develop Array-Based Ovarian Cancer Screen

The deal with WSU is the latest in a string of collaborations initiated by Arrayit to jumpstart the diagnostics subsidiary it founded earlier this year. Arrayit believes such a test could enable clinicians to screen for early-stage ovarian cancer in asymptomatic women.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.